German Sleep-Wake Disorder Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2025
The German sleep-wake disorder market is estimated to grow at a CAGR of 6.2% during the forecast period. Germany is the major contributor to the healthcare sector in Europe. The factors such as the increasing prevalence of behavioral health disorders, considerable resources of mental health, and a sophisticated healthcare system are the key factors that are expected to promote the growth of the market in the near future. As per WHO, the government’s total expenditure on mental health was 11.27% of the total government health expenditure in 2017. Additionally, total mental health expenditure per person was around $392 in 2017.
The market is segmented on the basis of type and treatment.
Based on type, the market is sub-segmented into insomnia, hypersomnia, sleep
apnea, circadian rhythm disorders, and others. Sleep apnea holds the largest
market share during the forecast period. On the basis of treatment, the market
is divide into therapies, drugs, and devices. The sleep-wake disorder devices
segment is estimated to hold the largest market share during the forecast
period, followed by medications. Some of the players operating in the market
include Koninklijke Philips N.V, Medtronic PLC, Sanofi SA, Jazz Pharmaceutical
Inc., and others.
To Request a Sample of our Report on German
Sleep-Wake Disorder Market: https://www.omrglobal.com/request-sample/german-sleep-wake-disorder-market
In January 2020, Jazz
Pharmaceuticals, SK Biopharmaceutical’s US partner received sales approval from
the European Medicine Agency (EMA) for Sunosi (Ingredient: solriamfetol), a
treatment for improving wakefulness in patients suffering from excessive daytime
sleepiness related with narcolepsy or obstructive sleep apnea. SK
Biopharmaceutical discovered Sunosi and completed its phase 1 clinical trial
before licensing out the substance to Aerial BioPharma in 2011. Thereafter,
Jazz Pharmaceuticals took over the global commercialization rights, including
the US and Europe, for completing the phase 3 clinical trials for the drug.
With this approval, Jazz Pharma has planned to launch Sunosi in Germany in
mid-2020 and then to France and UK by early 2021.
(Get 15% Discount on Buying this Report)
A
full Report of German Sleep-Wake Disorder Market is Available @ https://www.omrglobal.com/industry-reports/german-sleep-wake-disorder-market
Sleep-Wake Disorder Market Segmentation
By Type
·
Insomnia
·
Hypersomnia
·
Circadian Rhythm Disorders
·
Others
By Treatment
·
Therapies
·
Drugs
·
Devices
Company Profiles
·
Arena Pharmaceuticals, Inc.
·
Acorda Therapeutics, Inc.
·
Jazz Pharmaceuticals Inc.
·
Koninklijke Philips N.V.
·
LivaNova PLC
·
Medtronic PLC
·
Natus Medical Inc.
·
Pfizer Inc.
·
Sanofi SA
·
SomnoMed AG
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment